Published in Nat Genet on February 01, 2000
Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest (2002) 2.85
Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J (2001) 2.37
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol (2004) 2.30
c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest (2003) 2.19
JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J (2000) 2.05
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol (2004) 1.77
Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol (2002) 1.75
The human airway epithelial basal cell transcriptome. PLoS One (2011) 1.69
Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J Clin Invest (2010) 1.54
The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J (2004) 1.46
Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc Natl Acad Sci U S A (2008) 1.35
Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev (2000) 1.33
Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis (2002) 1.33
Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond. Front Immunol (2014) 1.29
Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol (2002) 1.26
Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr (2012) 1.18
Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism. J Biol Chem (2008) 1.16
Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol (2005) 1.15
A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev (2013) 1.15
Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res (2002) 1.13
c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest (2006) 1.08
Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J Exp Med (2003) 1.04
Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation. J Bone Miner Res (2010) 1.02
RANKing c-Jun in osteoclast development. J Clin Invest (2004) 1.01
Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genomics (2009) 1.00
Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation. J Cell Sci (2007) 1.00
Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. Cell Metab (2014) 0.99
RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. J Bone Miner Res (2007) 0.98
Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome. Anesthesiology (2015) 0.95
The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival. J Biol Chem (2010) 0.95
HDAC3 and HDAC7 have opposite effects on osteoclast differentiation. J Biol Chem (2011) 0.95
Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis. Clin Rheumatol (2006) 0.95
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells. J Exp Med (2014) 0.94
Signalling in osteoclasts and the role of Fos/AP1 proteins. Ann Rheum Dis (2003) 0.91
LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling. Mol Cell Biol (2013) 0.91
Understanding and targeting osteoclastic activity in prostate cancer bone metastases. Curr Mol Med (2013) 0.87
1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab (2009) 0.87
Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts. World J Orthop (2012) 0.86
Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis. J Biol Chem (2008) 0.86
Dynamics of the metal-dependent transcription factor complex in vivo at the mouse metallothionein-I promoter. Nucleic Acids Res (2003) 0.86
Nuclear receptors in bone physiology and diseases. Physiol Rev (2013) 0.86
Dysregulation of Mitochondrial Functions and Osteogenic Differentiation in Cisd2-Deficient Murine Induced Pluripotent Stem Cells. Stem Cells Dev (2015) 0.84
Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem (2012) 0.84
Impaired vibration of auditory ossicles in osteopetrotic mice. Am J Pathol (2011) 0.84
c-Fos-deficient mice are susceptible to Salmonella enterica serovar Typhimurium infection. Infect Immun (2006) 0.82
The role of the basal stem cell of the human breast in normal development and cancer. Adv Exp Med Biol (2011) 0.81
High glucose inhibits receptor activator of nuclear factor‑κB ligand-induced osteoclast differentiation via downregulation of v‑ATPase V0 subunit d2 and dendritic cell‑specific transmembrane protein. Mol Med Rep (2014) 0.80
Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. Osteoporos Int (2005) 0.79
Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations. PLoS One (2015) 0.79
Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis. BMC Syst Biol (2014) 0.79
Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways. PLoS One (2013) 0.79
Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65. J Bone Miner Metab (2008) 0.78
Diacylglycerol Kinase ζ (DGKζ) Is a Critical Regulator of Bone Homeostasis Via Modulation of c-Fos Levels in Osteoclasts. J Bone Miner Res (2015) 0.77
Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. J Biol Chem (2014) 0.77
Osteogenic capillaries orchestrate growth plate-independent ossification of the malleus. Development (2015) 0.75
The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis. J Immunol (2016) 0.75
E proteins regulate osteoclast maturation and survival. J Bone Miner Res (2012) 0.75
Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells. BMC Complement Altern Med (2014) 0.75
FIAT deletion increases bone mass but does not prevent high-fat-diet-induced metabolic complications. Endocrinology (2016) 0.75
Class II and IV HDACs function as inhibitors of osteoclast differentiation. PLoS One (2017) 0.75
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (1985) 7.54
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (1994) 5.97
Strain-dependent epithelial defects in mice lacking the EGF receptor. Science (1995) 5.22
Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature (1997) 5.08
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev (1995) 4.54
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol (1989) 4.46
Legitimate double-think. Lancet (1993) 4.31
Bone and haematopoietic defects in mice lacking c-fos. Nature (1993) 4.07
AP-1 in mouse development and tumorigenesis. Oncogene (2001) 3.93
Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell (1994) 3.91
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet (1999) 3.42
Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol (1999) 3.29
PARP is important for genomic stability but dispensable in apoptosis. Genes Dev (1997) 3.20
The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc Natl Acad Sci U S A (1981) 2.93
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell (1990) 2.77
Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Adolesc Psychiatry (1996) 2.69
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
To the point of farce: a Martian view of the Hardinian taboo--the silence that surrounds population control. BMJ (1997) 2.68
Helping health professionals involved in cancer care acquire key interviewing skills--the impact of workshops. Eur J Cancer (1996) 2.62
Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter. EMBO J (1985) 2.60
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60
Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol (1987) 2.59
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development (2000) 2.43
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med (2000) 2.36
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell (1988) 2.36
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
Resorption of bone by isolated rabbit osteoclasts. J Cell Sci (1984) 2.33
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32
Second opinions: a right or a concession? BMJ (1995) 2.25
The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell (2000) 2.22
Pulling the plug on futility. BMJ (1995) 2.19
Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J (1987) 2.16
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell (1989) 2.14
Helping cancer patients disclose their concerns. Eur J Cancer (1996) 2.11
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
A universal retroviral vector for efficient constitutive expression of exogenous genes. Nucleic Acids Res (1987) 2.11
Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology (1996) 2.09
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
Primary biliary cirrhosis is associated with falls and significant fall related injury. QJM (2010) 2.08
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med (1997) 2.07
Calcitonin alters behaviour of isolated osteoclasts. J Pathol (1982) 2.06
JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J (2000) 2.05
Multinucleate giant cells. J Pathol (1978) 2.04
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature (1994) 2.03
Colonic adenomas--a colonoscopy survey. Gut (1979) 2.01
Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med (1999) 1.98
Does breastfeeding method influence infant weight gain? Arch Dis Child (2007) 1.94
Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology (1996) 1.87
A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J (1998) 1.86
Functions of c-Jun in liver and heart development. J Cell Biol (1999) 1.85
The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell (2000) 1.81
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med (2001) 1.81
Clustered homeo boxes are differentially expressed during murine development. Cell (1985) 1.80
Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci U S A (1993) 1.80
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79
Fos is an essential component of the mammalian UV response. EMBO J (1995) 1.73
Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J (1997) 1.70
Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol (1993) 1.70
Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. Virology (1993) 1.70
Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev (1997) 1.69
Guidelines for compatibility procedures in blood transfusion laboratories. Transfus Med (2004) 1.67
Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Arch Gen Psychiatry (1991) 1.65
Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64
Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line. Cell (1983) 1.63
Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. Virology (1994) 1.63
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63
Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway. Plant Cell (2001) 1.62
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med (2012) 1.60
Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1980) 1.58
JunB is essential for mammalian placentation. EMBO J (1999) 1.57
Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem (1995) 1.56
The granuloma in Crohn's disease. Gut (1979) 1.54
Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology (1986) 1.52
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet (1997) 1.52
UNICEF's call to greatness--an open letter to Ms Carol Bellamy, Executive Director, United Nations Children's Fund. Natl Med J India (1996) 1.51
Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J (1987) 1.51
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med (1986) 1.50
Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol (1988) 1.49
Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. EMBO J (1985) 1.48
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47
c-erbB-2 expression in benign and malignant breast disease. Br J Cancer (1988) 1.47
Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ (1995) 1.46
Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol (1990) 1.46
A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J (1991) 1.46